A study published in Nature by the 23andMe Research Institutethe new nonprofit entity founded by the companys co-founder, Anne Wojcicki, for $305 million to replace the bankrupt biotechnology companysuggests the answer may be found, at least in part, in something far more fundamental than diet or willpower: our genes
Carls G, Huynh J, Tuttle E, Yee J, Edelman SV
doi: 10.1038/nrcardio.2014.59 53 SarzaniRGiuliettiFDi PentimaCSpannellaF
doi: 10.7326/AITC202406180 4 HammanRFBellRADabeleaDDAgostinoRBDolanLImperatoreGet al
I see it with my patients consistently: losing weight and keeping it off are two entirely different biological challenges. Unlike traditional GLP-1 medications, Lemme Metabolism isnt targeting brain receptors to suppress appetite or increase satiety
I have been tracking data and decided to do a deep dive going back 5 yrs (Dec 2020 - Jan 2026) to see what I find